HomePortfolios10 year plan (available)

10 year plan (available)

10 year plan

Created byuser-o6gmk2
Optimize
None Rebalancing
EUR
Moderate Risk
2.1yr backtest

Performance Summary

Total Return+26.52%
Annualized Return+12.15%
Volatility+13.31%
Sharpe Ratio0.76
Max Drawdown+19.21%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
Long-term global ETF portfolio with US, European, and emerging markets exposure for diversified growth over a decade.
AssetTypeAllocationTER
EXUS.XETRA
Xtrackers MSCI World ex USA UCITS ETF 1C • IE0006WW1TQ4
ETF
30.0%0.15%
ZA30.XETRA
iShares S&P 500 Scored and Screened UCITS ETF USD (Acc) • IE000R9FA4A0
ETF
30.0%0.07%
IS3N.XETRA
iShares Core MSCI Emerging Markets IMI UCITS • IE00BKM4GZ66
ETF
15.0%0.18%
EUNK.XETRA
iShares Core MSCI Europe UCITS ETF EUR (Acc) • IE00B4K48X80
ETF
15.0%0.12%
IUSN.XETRA
iShares MSCI World Small Cap UCITS ETF • IE00BF4RFH31
ETF
10.0%0.35%
Total100.0%0.15%

Performance

Portfolio Value Over Time
Starting with €10,000 investment → now worth €12,651.71
Histogram of Monthly Returns
The portfolio had a positive return during 18 of the 26 months (69%)
Monthly Returns Heatmap
Best month: +5.4% • Worst month: -6.7% • Best year: 2025 (+13.0%) • Worst year: 2026 (+1.3%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026+2.9%+3.3%-6.7%+2.2%--------+1.3%
2025+4.3%-0.8%-5.7%-3.3%+5.4%+0.7%+3.6%+0.6%+2.6%+4.0%+0.1%+1.3%+13.0%
2024--+2.6%-1.3%+1.6%+2.7%+1.0%-0.3%+1.5%-0.7%+4.8%-1.6%+10.5%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +19.21% • The longest drawdown period lasted for 6 months and was between February 2025 and September 2025. It reached a trough of -19.2%.

Detailed Metrics

Returns
Total Return
+26.52%
Annualized Return
+12.15%
Avg Monthly Return
+0.95%
Risk
Volatility (Annual)
+13.31%
Max Drawdown
+19.21%
Positive Months
69%
Average Drawdown
-2.9%
Risk-Adjusted
Sharpe Ratio
0.76
Risk-free rate: 2.0%
Sortino Ratio
0.70
Downside risk adjusted
Return/Volatility
0.91
Calmar Ratio
0.63
Return/Max Drawdown
Ulcer Index
3.90
Drawdown depth & duration
Martin Ratio
0.03
Return/Ulcer Index
Backtest Configuration
Initial Investment
€10,000
Final Value
€12,651.71
Backtest Period
2024-03-14 to 2026-04-02
2.1 years
Rebalancing
none
Base Currency
EUR